Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
about
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) studyThyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis.Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosis.
P2860
Q22241650-0BF84595-28A8-429A-B9B5-A111BC676309Q27024667-B20D9D94-F2D0-479A-B21D-688B0BCF990AQ34810005-EA7235AA-DA0D-46F1-8E14-863E8E1F6931Q37071396-C192D3AA-B1EE-4043-BB35-597CCFA622ECQ37478921-1E4D6CA6-2961-4499-854E-7A67A98A7B53Q37614062-6308D65B-C70B-4F6E-BF61-6E3CD67CDA3BQ42920232-5C9997AD-C5F3-4AC9-BBE4-6C04F519BE38Q43442571-14D5EDC3-3878-44FF-8210-4FA28BCEFC75
P2860
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@ast
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@en
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@nl
type
label
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@ast
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@en
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@nl
prefLabel
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@ast
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@en
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@nl
P2093
P2860
P1476
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
@en
P2093
A Clemenzi
C Buttinelli
C Pozzilli
G Borriello
P2860
P304
P356
10.1111/J.1468-1331.2007.01969.X
P407
P577
2007-11-01T00:00:00Z